$QCOM
QUALCOMM INC/DE

2024 Q2 Form 10-Q Financial Statement

#000080432824000039 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $9.393B $9.389B
YoY Change 11.15% 1.23%
Cost Of Revenue $4.174B $4.106B
YoY Change 10.07% -1.13%
Gross Profit $5.219B $5.283B
YoY Change 12.02% 3.14%
Gross Profit Margin 55.56% 56.27%
Selling, General & Admin $664.0M $707.0M
YoY Change 7.44% 15.15%
% of Gross Profit 12.72% 13.38%
Research & Development $2.259B $2.236B
YoY Change 1.67% 1.18%
% of Gross Profit 43.28% 42.32%
Depreciation & Amortization $419.0M $411.0M
YoY Change -12.53% -12.55%
% of Gross Profit 8.03% 7.78%
Operating Expenses $2.923B $2.943B
YoY Change 2.96% 4.21%
Operating Profit $2.221B $2.340B
YoY Change 22.03% 11.96%
Interest Expense $168.0M $172.0M
YoY Change -429.41% -3.91%
% of Operating Profit 7.56% 7.35%
Other Income/Expense, Net $226.0M $330.0M
YoY Change 5550.0% -2162.5%
Pretax Income $2.279B $2.498B
YoY Change 29.71% 31.82%
Income Tax $171.0M $223.0M
% Of Pretax Income 7.5% 8.93%
Net Earnings $2.129B $2.326B
YoY Change 18.08% 36.5%
Net Earnings / Revenue 22.67% 24.77%
Basic Earnings Per Share $1.91 $2.08
Diluted Earnings Per Share $1.88 $2.06
COMMON SHARES
Basic Shares Outstanding 1.116B shares 1.116B shares
Diluted Shares Outstanding 1.134B shares 1.130B shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.03B $13.85B
YoY Change 50.99% 107.47%
Cash & Equivalents $7.770B $9.219B
Short-Term Investments $5.262B $4.632B
Other Short-Term Assets $1.332B $1.240B
YoY Change -2.56% 20.16%
Inventory $6.020B $6.087B
Prepaid Expenses
Receivables $2.948B $3.054B
Other Receivables $0.00 $0.00
Total Short-Term Assets $23.33B $24.23B
YoY Change 13.95% 27.05%
LONG-TERM ASSETS
Property, Plant & Equipment $4.744B $4.724B
YoY Change -9.05% -10.55%
Goodwill $10.77B $10.76B
YoY Change 1.69% 1.71%
Intangibles $1.296B $1.331B
YoY Change -19.9% -22.93%
Long-Term Investments
YoY Change
Other Assets $8.179B $8.142B
YoY Change -26.32% 2.11%
Total Long-Term Assets $29.41B $28.94B
YoY Change 3.1% -1.21%
TOTAL ASSETS
Total Short-Term Assets $23.33B $24.23B
Total Long-Term Assets $29.41B $28.94B
Total Assets $52.74B $53.17B
YoY Change 7.63% 9.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.586B $2.314B
YoY Change 48.28% 61.82%
Accrued Expenses $1.780B $1.253B
YoY Change 15.14% 2.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.364B $914.0M
YoY Change 49.23%
Total Short-Term Liabilities $9.747B $9.143B
YoY Change 15.17% 16.23%
LONG-TERM LIABILITIES
Long-Term Debt $13.19B $14.54B
YoY Change -9.22% -6.09%
Other Long-Term Liabilities $5.134B $5.012B
YoY Change -3.84% -5.65%
Total Long-Term Liabilities $18.32B $19.56B
YoY Change -7.78% -5.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.747B $9.143B
Total Long-Term Liabilities $18.32B $19.56B
Total Liabilities $28.07B $28.70B
YoY Change -0.92% 0.12%
SHAREHOLDERS EQUITY
Retained Earnings $24.27B $23.97B
YoY Change 20.38% 24.3%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.67B $24.47B
YoY Change
Total Liabilities & Shareholders Equity $52.74B $53.17B
YoY Change 7.63% 9.94%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $2.129B $2.326B
YoY Change 18.08% 36.5%
Depreciation, Depletion And Amortization $419.0M $411.0M
YoY Change -12.53% -12.55%
Cash From Operating Activities $3.052B $3.554B
YoY Change 14.87% 143.93%
INVESTING ACTIVITIES
Capital Expenditures $387.0M $184.0M
YoY Change 26.47% -59.38%
Acquisitions
YoY Change
Other Investing Activities -$656.0M -$755.0M
YoY Change -132.11% -429.69%
Cash From Investing Activities -$1.043B -$939.0M
YoY Change -160.05% 319.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.449B -1.580B
YoY Change 73.49% -37.87%
NET CHANGE
Cash From Operating Activities 3.052B 3.554B
Cash From Investing Activities -1.043B -939.0M
Cash From Financing Activities -3.449B -1.580B
Net Change In Cash -1.440B 1.035B
YoY Change -159.85% -179.01%
FREE CASH FLOW
Cash From Operating Activities $3.052B $3.554B
Capital Expenditures $387.0M $184.0M
Free Cash Flow $2.665B $3.370B
YoY Change 13.36% 235.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1118000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1118000000 shares
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24469000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19698000000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.60
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
176000000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4096000000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2150000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
6422000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2195000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-357000000 usd
us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
799000000 usd
us-gaap Proceeds From Issuance Of Commercial Paper
ProceedsFromIssuanceOfCommercialPaper
4668000000 usd
us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
799000000 usd
us-gaap Repayments Of Commercial Paper
RepaymentsOfCommercialPaper
4668000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1880000000 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1446000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
232000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1515000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2173000000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
1790000000 usd
us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
1676000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
515000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
332000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-43000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3621000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3558000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
692000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
683000000 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
77000000 usd
CY2022Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
326000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8527000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3099000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9219000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23058000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18810000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21581000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
18013000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24469000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19698000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.80
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
us-gaap Fiscal Period
FiscalPeriod
We operate and report using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three and six months ended March 24, 2024 and March 26, 2023 included 13 weeks and 26 weeks, respectively.
us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in our condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
157000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3670000000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2260000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
6087000000 usd
CY2024Q1 srt Payables To Customers
PayablesToCustomers
2441000000 usd
CY2023Q3 srt Payables To Customers
PayablesToCustomers
1821000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1093000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1717000000 usd
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
875000000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
953000000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4409000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4491000000 usd
CY2024Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
55000000 usd
CY2023Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
170000000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
206000000 usd
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
337000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
227000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
241000000 usd
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
160000000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
59000000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
312000000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
114000000 usd
CY2024Q1 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-3000000 usd
CY2023Q1 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
9000000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
8000000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
20000000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
155000000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 usd
us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
159000000 usd
us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 usd
CY2024Q1 qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
62000000 usd
CY2023Q1 qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
21000000 usd
qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
126000000 usd
qcom Net Losses Gains On Deferred Compensation Plan Assets
NetLossesGainsOnDeferredCompensationPlanAssets
47000000 usd
CY2024Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
50000000 usd
CY2023Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
87000000 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
62000000 usd
us-gaap Impairment Of Investments
ImpairmentOfInvestments
101000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
330000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
542000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
60000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.09
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.09
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1114000000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
15000000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
11000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1118000000 shares
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.80
CY2024Q1 qcom Amount Of Increased Common Stock Dividends Per Share Announced
AmountOfIncreasedCommonStockDividendsPerShareAnnounced
0.85
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13000000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
12000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000000 shares
CY2024Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
0 usd
CY2024Q1 us-gaap Revenues
Revenues
9389000000 usd
CY2023Q1 us-gaap Revenues
Revenues
9275000000 usd
us-gaap Revenues
Revenues
19325000000 usd
us-gaap Revenues
Revenues
18738000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2498000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1895000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5460000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4266000000 usd

Files In Submission

Name View Source Status
0000804328-24-000039-index-headers.html Edgar Link pending
0000804328-24-000039-index.html Edgar Link pending
0000804328-24-000039.txt Edgar Link pending
0000804328-24-000039-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qcom-20240324.htm Edgar Link pending
qcom-20240324.xsd Edgar Link pending
qcom032424ex105.htm Edgar Link pending
qcom032424ex311.htm Edgar Link pending
qcom032424ex312.htm Edgar Link pending
qcom032424ex321.htm Edgar Link pending
qcom032424ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qcom-20240324_def.xml Edgar Link unprocessable
qcom-20240324_lab.xml Edgar Link unprocessable
qcom-20240324_pre.xml Edgar Link unprocessable
qcom-20240324_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qcom-20240324_cal.xml Edgar Link unprocessable